Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Sekine, Takuya, Perez-Potti, André, Rivera-Ballesteros, Olga, Strålin, Kristoffer, Gorin, Jean-Baptiste, Olsson, Annika, Llewellyn-Lacey, Sian, Kamal, Habiba +70 more·2020·Cell

DOI 10.1016/j.cell.2020.08.017

Cited by (1,002)

Items 901–1,000 of 1,002

Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study
Joshua Nazareth, Christopher Andrew Martin, Daniel Pan, Ian Barr, Sheena G. Sullivan, Heidi Peck, Neyme Veli, Mrinal Das, Luke Bryant, Nisha Ajit George et al. · 2024 · The Lancet Regional Health - Europe
Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in mice
Shailendra Kumar Verma, Fernanda Ana‐Sosa‐Batiz, Julia Timis, Norazizah Shafee, Erin Maule, Paolla Beatriz Almeida Pinto, Chris Conner, Kristen M. Valentine, Dale O. Cowley, Robyn Miller et al. · 2024 · EBioMedicine
mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases
Rossella Brandi, Alessia Paganelli, Raffaele D’Amelio, Paolo Giuliani, Florigio Romano Lista, Simonetta Salemi, Roberto Paganelli · 2024 · Vaccines
The immunopathogenesis of SARS-CoV-2 infection: Overview of lessons learned in the first 5 years
Otto O. Yang · 2025 · The Journal of Immunology
Mortality and pulmonary complications in patients undergoing upper extremity surgery at the peak of the SARS-CoV-2 pandemic in the UK: a national cohort study
Benjamin John Floyd Dean · 2020 · BMJ Quality & Safety
The COVID-19 pandemic through eyes of a NYC fertility center: a unique learning experience with often unexpected results
Norbert Gleicher · 2020 · Reproductive Biology and Endocrinology
SARS CoV-2 infections in healthcare workers with a pre-existing T-cell response: a prospective cohort study
José L. Casado, Johannes Häemmerle, Pilar Vizcarra, Héctor Velasco, Tamara Velasco, Marina Fernández-Escribano, Alejandro Vallejo · 2021 · Clinical Microbiology and Infection
Could Antigen Presenting Cells Represent a Protective Element during SARS-CoV-2 Infection in Children?
Rita Lauro, Natasha Irrera, Ali Hussein Eid, Alessandra Bitto · 2021 · Pathogens
AIDS and COVID: A tale of two pandemics and the role of statisticians
Susan S. Ellenberg, Jeffrey S. Morris · 2021 · Statistics in Medicine
Allergy: Type I, II, III, and IV
Edward F. Knol, Stefanie Gilles · 2021 · Handbook of experimental pharmacology
Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression
Bastian Fischer, Christopher Lindenkamp, Christoph Lichtenberg, Ingvild Birschmann, Cornelius Knabbe, Doris Hendig · 2021 · Life
Prevalence and determinants of serum antibodies to SARS-CoV-2 in the general population of the Gardena valley
Roberto Melotti, Federica Scaggiante, Michela Falciani, Christian X. Weichenberger, Luisa Foco, Stefano Lombardo, Alessandro De Grandi, Dorotheé von Laer, Angelika Mahlknecht, Peter Paul Pramstaller et al. · 2021 · Epidemiology and Infection
Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 Pandemic
Martin S. Weber, Jacqueline A. Nicholas, Michael R. Yeaman · 2021 · Neurology Neuroimmunology & Neuroinflammation
Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
Mosche Pompsch, Neslinur Fisenkci, Peter Alexander Horn, Markus Kraemer, Monika Lindemann · 2021 · Neurological Research and Practice
SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot
Lutz Achtnichts, А. К. Овчинников, Barbara Jakopp, Michael Oberle, Krassen Nedeltchev, Christoph Andreas Fux, Johann Sellner, Oliver Findling · 2022 · Vaccines
An Analysis of Serological Response and Infection Outcomes Following Oxford-AstraZeneca (AZD1222) and Pfizer-BioNTech (mRNA BNT162b2) SARS-CoV-2 Vaccines in Kidney and Kidney-pancreas Transplants
Argiris Asderakis, Usman Khalid, Georgios Koimtzis, Mark J. Ponsford, Laszlo Szabo, Christopher Chalklin, Kathryn Bramhall, Leanne Grant, Stuart J. Moat, Ian Robert Humphreys et al. · 2022 · Transplantation
Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing
Han Bai, Junpeng Ma, Weikang Mao, Xuan Zhang, Yijun Nie, Jingcan Hao, Xiaorui Wang, Hongyu Qin, Qiqi Zeng, Fang Hu et al. · 2022 · Blood Cells Molecules and Diseases
The lymphatic system and COVID-19 vaccines
Masayuki Miyasaka · 2022 · Frontiers in Immunology
Bioinformatic Analysis of B- and T-cell Epitopes from SARS-CoV-2 Structural Proteins and their Potential Cross-reactivity with Emerging Variants and other Human Coronaviruses
Diana Laura Pacheco-Olvera, Stephanie Saint Remy-Hernández, María Guadalupe García-Valeriano, Tania Rivera-Hernández, Constantino III Roberto López-Macías · 2022 · Archives of Medical Research
Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals
Ambra Natalini, Sonia Simonetti, Carmel Sher, Ugo D’Oro, Adrian Hayday, Francesca Di Rosa · 2022 · International Journal of Molecular Sciences
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms
Diego M. Cantoni, Gabriel Siracusano, Martin Mayora Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, on behalf of the Ambulatorio Medico San Luca Villanuova Group, Lucia Lopalco et al. · 2022 · Vaccines
Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic
Katarzyna Kapten, Krzysztof Orczyk, Elżbieta Barbara Smolewska · 2023 · Archivum Immunologiae et Therapiae Experimentalis
Can T Cells Abort SARS-CoV-2 and Other Viral Infections?
Leo Swadling, Mala K. Maini · 2023 · International Journal of Molecular Sciences
Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2
Jolie M. Phan, Erik D. Layton, Krystle K. Q. Yu, Melissa S. Aguilar, Inah Golez, Nicholas Franko, Jennifer K. Logue, Lauren B. Rodda, Christian A. Howard, Marion Pepper et al. · 2023 · The Journal of Immunology
Kinetics of cellular and humoral immunogenicity and effectiveness of SARS‐CoV ‐2 booster vaccination in hematologic neoplasms
Moraima Jiménez, Candela Fernández‐Naval, Vı́ctor Navarro, Sandra Novoa Jáuregui, Mónica Martínez‐Gallo, Daniel Medina-Gil, Cristina Andrés, Andrés Antón, Soraya Peralta, Gemma Pujadas et al. · 2023 · American Journal of Hematology
T cell control of SARS-CoV-2: When, which, and where?
Mariana O. Diniz, Mala K. Maini, Leo Swadling · 2023 · Seminars in Immunology
Prevalence of SARS-CoV-2 Specific Antibodies in Asymptomatic Hemodialysis Patients
Jalal Etemadi, Shima Bordbar, Mohammad Sadegh Soltani‐Zangbar, Mahsa Hajivalili, Leili Aghebati Maleki, Roza Motavalli, Ata Mahmoodpoor, Sima Shahmohammadi Farid, Sima Abedi Azar, Bahram Niknafs et al. · 2021 · Immunological Investigations
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave
Nicola A. Sweeney, Blair Merrick, Rui Pedro Galão, Suzanne Pickering, Alina Botgros, Harry Wilson, Adrian W. Signell, Gilberto Betancor, Mark Tan Kia Ik, John Ramble et al. · 2021 · PLoS ONE
A flow cytometry-based proliferation assay for clinical evaluation of T-cell memory against SARS-CoV-2
Sara Lind Enoksson, Peter Bergman, Jonas Klingström, Fredrik Boström, Rui Da Silva Rodrigues, Malin Elisabeth Winerdal, Per Marits · 2021 · Journal of Immunological Methods
Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies
Chaojie Zhong, Hongjie Xia, Awadalkareem Adam, Binbin Wang, Renee L. Hajnik, Yuejin Liang, Grace H. Rafael, Jing Zou, Xiaofang Wang, Jiaren Sun et al. · 2021 · npj Vaccines
Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology
Aaruni Khanolkar · 2021 · Cells
Melatonin and REGN-CoV2 combination as a vaccine adjuvant for Omicron variant of SARS-CoV-2
Ismail Celil Haskologlu, Emine Erdağ, Serkan Sayıner, Nurettin Abacıoğlu, Ahmet Özer Şehirli · 2022 · Molecular Biology Reports
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine
Federica Dominelli, Maria Antonella Zingaropoli, Matteo Tartaglia, Eeva Tortellini, Mariasilvia Guardiani, Valentina Perri, Patrizia Pasculli, Federica Ciccone, Leonardo Malimpensa, Viola Baione et al. · 2022 · Frontiers in Immunology
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
Ralf Duerr, Keaton M. Crosse, Ana M. Valero-Jimenez, Meike Dittmann · 2021 · Microorganisms
COVID-19: impact on Public Health and hypothesis-driven investigations on genetic susceptibility and severity
Susana David, Guillermo Dorado, Elsa Leclerc Duarte, Stéphanie David-Bosne, João M. Trigueiro-Louro, Helena Rebelo‐de‐Andrade · 2022 · Immunogenetics
Longitudinal analysis of the humoral response to SARS-CoV-2 spike RBD in convalescent plasma donors
Josée Perreault, Tony Tremblay, Marie‐Josée Fournier, Mathieu Drouin, Guillaume Beaudoin-Bussières, Jérémie Prévost, Antoine Lewin, Philippe Bégin, Andrés Finzi, Renée Bazin · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Long-Term, CD4+ Memory T Cell Response to SARS-CoV-2
Sebastian Wirsching, Laura H. Harder, Markus Heymanns, Britta Gröndahl, Katja Hilbert, Frank Kowalzik, Claudius U. Meyer, Stephan Gehring · 2022 · Frontiers in Immunology
SARS-CoV2 mRNA Vaccine-Specific B-, T- and Humoral Responses in Adolescents After Kidney Transplantation
Arne Sattler, Julia Thumfart, Laura Toth, Eva Vanessa Schrezenmeier, Vanessa Proß, Carolin Stahl, Janine Siegle, An He, Linda Marie Laura Thole, Carolin Ludwig et al. · 2022 · Transplant International
The DNA-based Lassa vaccine INO-4500 confers durable protective efficacy in cynomolgus macaques against lethal Lassa fever
Viviane M. Andrade, Kathleen A. Cashman, Kyle Rosenke, Eric R. Wilkinson, Nicole M. Josleyn, Ginger C. Lynn, Jesse T. Steffens, Sean A. Van Tongeren, Jay Wells, Connie S. Schmaljohn et al. · 2024 · Communications Medicine
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya
Doreen I. Lugano, Bernadette Kutima, Makobu Kimani, Antipa K. Sigilai, John N. Gitonga, Angela Karani, Donald O. Akech, Boniface Karia, Abdhalah Kasiira Ziraba, Angela W. Maina et al. · 2024 · BMC Infectious Diseases
SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development
Àlex Olvera, Marc Noguera-Julián, Athina Kilpeläinen, Luis Romero-Martín, Júlia G. Prado, Christian Brander · 2020 · Vaccines
Telemedicine follow-ups for COVID-19: Experience in a tertiary hospital
Javier Nogueira López, Carlos Daniel Grasa, Cristina Ots Ruiz, Luis Alonso García, Iker Falces‐Romero, Cristina Calvo, Milagros García-López Hortelano · 2021 · Anales de Pediatría (English Edition)
Adaptive immune responses to SARS-CoV-2
Donald N. Forthal · 2021 · Advanced Drug Delivery Reviews
The COVID‐19 pandemic: key considerations for the epidemic and its control
Søren Ørskov, Bjarke Frost Nielsen, Sofie Føns, Kim Sneppen, Lone Simonsen · 2021 · Apmis
Cutting Edge: Lung-Resident T Cells Elicited by SARS-CoV-2 Do Not Mediate Protection against Secondary Infection
Lydia M. Roberts, Forrest Jessop, Tara D. Wehrly, Catharine M. Bosio · 2021 · The Journal of Immunology
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines
Andrea Picchianti Diamanti, Maria Manuela Rosado, Emanuele Nicastri, Giorgio Sesti, Claudio Pioli, Bruno Laganà · 2021 · Frontiers in Immunology
SARS-CoV-2–specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19
Dominique Bertrand, Mouad Hamzaoui, Laurent Drouot, Julie Lamulle, Mélanie Hanoy, Stéphane Edet, Charlotte Laurent, Ludivine Lebourg, Isabelle Etienne, Mathilde Lemoine et al. · 2021 · Transplantation Direct
A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization
Sameer-ul-Salam Mattoo, Jinjong Myoung · 2021 · Journal of Microbiology and Biotechnology
Evidence of a SARS-CoV-2 double Spike mutation D614G/S939F potentially affecting immune response of infected subjects
Sara Donzelli, Francesca Spinella, Enea Gino Di Domenico, Martina Pontone, Ilaria Cavallo, Giulia Orlandi, Stefania Iannazzo, Giulio Maria Ricciuto, ISG Virology Covid Team, Raul Pellini et al. · 2022 · Computational and Structural Biotechnology Journal
Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines
Simone Pecetta, Sven Kratochvil, Yu Kato, Kumaran Vadivelu, Rino Rappuoli · 2022 · Pharmacological Reviews
Progress and Challenges Toward Generation and Maintenance of Long-Lived Memory T Lymphocyte Responses During COVID-19
Swatantra Kumar, Shailendra Kumar Saxena, Vimal K. Maurya, Anil Kumar Tripathi · 2022 · Frontiers in Immunology
COVID-19: Immune response
Hyam Raouf Al-Hamamy · 2022 · Research Journal of Pharmacy and Technology
An Update on Protective Effectiveness of Immune Responses After Recovery From COVID-19
Saeede Soleimanian, Soheila Sadat Alyasin, Najmeh Sepahi, Zahra Ghahramani, Zahra Kanannejad, Ramin Yaghobi, Mohammad Hossein Karimi · 2022 · Frontiers in Immunology
A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects
Farokh Dotiwala, Arun K. Upadhyay · 2022 · Frontiers in Immunology
Nanovaccines to combat virus‐related diseases
Fuhua Wu, Ming Qin, Hairui Wang, Xun Sun · 2022 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2
Maria Agallou, Olga S. Koutsoni, Maria Michail, Paraskevi Zisimopoulou, Ourania Tsitsilonis, Evdokia Karagouni · 2022 · The Journal of Infectious Diseases
Functional studies of HLA and its role in SARS-CoV-2: Stimulating T cell response and vaccine development
Lin Feng, Xiaoyuan Lin, Beibei Fu, Yan Xiong, Mohamed Y. Zaky, Haibo Wu · 2023 · Life Sciences
CuMV VLPs Containing the RBM from SARS-CoV-2 Spike Protein Drive Dendritic Cell Activation and Th1 Polarization
Ana Isabel Sebastião, Daniela Mateus, Mylène A. Carrascal, Cátia Sousa, Luísa Cortes, Martin F. Bachmann, Anália do Carmo, Ana Miguel Matos, M. Goreti F. Sales, Maria Teresa Cruz · 2023 · Pharmaceutics
Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
Rupsha Fraser, Aurelio Orta Resendiz, David Harold Dockrell, Michaela C. Müller-Trutwin, Alexander Mazein · 2023 · European Respiratory Review
T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis
Ayumi Yoshifuji, Masataro Toda, Munekazu Ryuzaki, Emi Oyama, Kan Kikuchi, Toru Kawai, Ken Sakai, Masayoshi Koinuma, Kazuhiko Katayama, Takashi Yokoyama et al. · 2023 · Vaccines
Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity
Maria-Myrto Dourdouna, Elizabeth‐Barbara Tatsi, Vasiliki Syriopoulou, Athanasios G. Michos · 2023 · Diagnostic Microbiology and Infectious Disease
Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals
Natasha J. Norton, Kayla A. Holder, Danielle P. Ings, Debbie O. A. Harnum, Rodney S. Russell, Michael D. Grant · 2023 · Viruses
Considerations for Choosing T Cell Assays during a Pandemic
Jaclyn C. Law, Tania H. Watts · 2023 · The Journal of Immunology
Health disparities in COVID-19: immune and vascular changes are linked to disease severity and persist in a high-risk population in Riverside County, California
Kristina V. Bergersen, Kathy Pham, Jiang Li, Michael T. Ulrich, Patrick Merrill, Yuxin He, Sumaya Troy Alaama, Xinru Qiu, Indira S. Harahap-Carrillo, Keita Ichii et al. · 2023 · BMC Public Health
The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses
Mithil Soni, Edoardo Migliori, Jianing Fu, Amer Assal, Hei Ton Chan, Jian Pan, Prabesh Khatiwada, Rodica Ciubotariu, Michael S. May, Marcus R. Pereira et al. · 2023 · Frontiers in Immunology
Memory T Cells Discrepancies in COVID-19 Patients
Hajir AlSaihati, Hosni A. M. Hussein, Ali A. Thabet, Ahmed A. Wardany, Sabry Younis Mahmoud, Eman S. Farrag, Taha I. A. Mohamed, Samah M. Fathy, Mohamed E. Elnosary, Ali Sobhy et al. · 2023 · Microorganisms
Mucosal SARS-CoV-2 vaccination of rodents elicits superior systemic T central memory function and cross-neutralising antibodies against variants of concern
Aled O’Neill, Chinmay Kumar Mantri, Chee Wah Tan, Wilfried A. A. Saron, Santhosh Kambaiah Nagaraj, Monica Palanichamy Kala, Christy M. Joy, Abhay P. S. Rathore, Shashank Tripathi, Lin‐Fa Wang et al. · 2023 · EBioMedicine
Special Review: The future of Immunotherapy
Cornelis J.M. Melief · 2020 · Immunotherapy Advances
Prevalence of SARS-CoV-2-Antibodies in Danish Children and Adults
Maren Johanne Heilskov Rytter, Ulrikka Nygaard, Ida Nikoline Mandic, Jonathan Peter Glenthøj, Lisbeth Samsø Schmidt, Dina Cortes, Birgitte Smith, Tatjana Zaharov, Mia Johanna Søndergaard, Marie Cecilie Lawaetz et al. · 2021 · The Pediatric Infectious Disease Journal
Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection
José L. Casado, Pilar Vizcarra, Hector Velasco, Johannes Häemmerle, Amaranta McGee Laso, Marina Fernández-Escribano, Alejandro Vallejo · 2021 · The Journal of Infectious Diseases
Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients
Oscar Guzmán-Martínez, Kathia Guardado, Miguel Varela Cardoso, Alejandro Trujillo-Rivera, Antonio Marı́n-Hernández, María Cristina Ortiz León, Iván Gómez-Ñañez, Michelle Gutiérrez, Rafaela Espinosa, Clara Luz Sampieri et al. · 2021 · Infection
Durability of Antibody Responses to SARS-CoV-2 Infection and Its Relationship to Disease Severity Assessed Using a Commercially Available Assay
Alanoud Alshami, Rabab A. Al Attas, Hadeel Anan, Aroub Al Maghrabi, Salim S. Ghandorah, Amani Mohammed, Abdulbary Ali Alhalimi, Jumana Mansour Al-Jishi, Hadi Alqahtani · 2021 · Frontiers in Microbiology
Role of the cellular immunity in the formation of the immune response in coronavirus infections
Ivanova Ia, N. D. Omelchenko, Anna V. Filippenko, Anastasia A. Trufanova, А. К. Носков · 2021 · Medical Immunology (Russia)
CD4+ T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects
Laura Esparcia-Pinedo, Pedro Martínez‐Fleta, Noelia Ropero, Paula Vera-Tomé, Hugh T. Reyburn, José M. Casasnovas, José Miguel Rodrı́guez-Frade, Mar Valés‐Gómez, Carlos Vilches, Enrique Martín‐Gayo et al. · 2022 · Frontiers in Immunology
Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients
Christa Meisinger, Yvonne Goßlau, Tobias Dominik Warm, Vincenza Leone, Alexander Hyhlik-Dürr, Jakob Linseisen, Inge Kirchberger · 2022 · Frontiers in Immunology
Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination
Laura Esparcia-Pinedo, Ayla Yarci-Carrión, Gloria Mateo-Jiménez, Noelia Ropero, Laura Gómez, A. Lancho, Patricia Almendro-Vázquez, Enrique Martín‐Gayo, Estela Paz‐Artal, Francisco Sánchez‐Madrid et al. · 2022 · Clinical Infectious Diseases
Deciphering the quality of SARS‐CoV‐2 specific T‐cell response associated with disease severity, immune memory and heterologous response
Alberto Pérez‐Gómez, Carmen Gasca‐Capote, Joana Vitallé, Francisco José Ostos, Ana Serna‐Gallego, María Trujillo‐Rodríguez, Esperanza Muñoz‐Muela, Teresa Giráldez‐Pérez, Julia Praena‐Segovia, María Dolores Navarro-Amuedo et al. · 2022 · Clinical and Translational Medicine
Profound CD8 T cell responses towards the SARS-CoV-2 ORF1ab in COVID-19 patients
Anastasia Gangaev, Steven L. C. Ketelaars, Sanne Patiwael, Anna Dopler, Olga I. Isaeva, Kelly Hoefakker, Sara De Biasi, Cristina Mussini, Giovanni Guaraldi, Massimo Girardis et al. · 2020
IL-2 and IFN-γ are biomarkers of SARS-CoV-2 specific cellular response in whole blood stimulation assays
Begoña Pérez‐Cabezas, Ricardo Jorge Teixeira Ribeiro, Inês Costa, Sofia Esteves, Ana Rafaela Teixeira, Teresa Reis, Ricardo Monteiro, Alexandre Afonso, Vítor César Arantes Pinheiro, Maria Isabel Antunes et al. · 2021 · medRxiv
Citoquinas pro y anti-inflamatorias en la infección por SARS-CoV-2, en población de Colombia
Gabriela Delgado, Carlos Álvarez, Diana Granados-Falla · 2020 · Infectio
Prevalence of SARS-CoV-2 in an Area of Unrestricted Viral Circulation: Mass Seroepidemiological Screening in Castiglione D’Adda, Italy
Gabriele Pagani, Andrea Giacomelli, Federico Conti, Dario Bernacchia, Rossana Rondanin, Andrea Prina, Vittore F. Scolari, Arianna Rizzo, Martina Beltrami, Camilla Caimi et al. · 2020 · PLoS ONE
Subunit protein CD40.SARS.CoV2 vaccine induces SARS-CoV-2-specific stem cell-like memory CD8+ T cells
Laury Nguema, Florence Picard, Marwa El Hajj, Léa Dupaty, Craig W. Fenwick, Sylvain Cardinaud, Aurélie Wiedemann, Giuseppe Pantaleo, Sandra Zurawski, Mireille Centlivre et al. · 2024 · EBioMedicine
A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine
Ismail Cem Yilmaz, Emre Mert İpekoğlu, Berfu Saraydar, Tugce Bildik, Aslı Gulce Bartan Aksoy, İrem Evcili, Nilsu Turay, Naz Sürücü, Artun Bulbul, Nese Guvencli et al. · 2025 · Vaccine
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
Hiam Naiditch, Michael R. Betts, H. Benjamin Larman, Moshe Levi, Avi Z. Rosenberg · 2025 · Frontiers in Immunology
T Cell Dynamics in COVID-19, Long COVID and Successful Recovery
Zoia R. Korobova, Natalia A. Arsentieva, Anastasia A. Butenko, Игорь Владимирович Кудрявцев, Artem Rubinstein, Anastasia S. Turenko, Yu. V. Ostankova, Ekaterina V. Boeva, Anastasia A. Knizhnikova, Anna O. Norka et al. · 2025 · International Journal of Molecular Sciences
SARS-CoV-2 Spike-Derived Peptides Presented by HLA Molecules
Andrea Nguyen, Christopher W. Szeto, Dhilshan Jayasinghe, Christian A. Lobos, Hanim Halim, Demetra S.M. Chatzileontiadou, Emma J. Grant, Stéphanie Gras · 2021 · Biophysica
Seguimiento telemático de COVID-19: experiencia de un hospital terciario
Javier Nogueira López, Carlos Daniel Grasa, Cristina Ots Ruiz, Luis Alonso García, Iker Falces‐Romero, Cristina Calvo, Milagros García-López Hortelano · 2020 · Anales de Pediatría
SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response.
Hadida Yasmin, Sudipta Saha, M. Butt, R. Modi, A. J. George, U. Kishore · 2021 · Advances in Experimental Medicine and Biology
Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice
Shant H. Mahrokhian, Lisa H. Tostanoski, Catherine Jacob-Dolan, Roland C. Zahn, Frank Wegmann, Katherine McMahan, Jingyou Yu, Makda S. Gebre, Esther Apraku Bondzie, Huahua Wan et al. · 2022 · npj Vaccines
The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates
Seung-Pil Shin, Kwangsoo Shin, Jeong-Mi Lee, In-Kyung Jung, Jimo Koo, Seung‐Woo Lee, Seowoo Park, Ji-eun Shin, Myung Hwan Park, Bongju Park et al. · 2022 · Vaccines
Human seasonal coronavirus neutralization and COVID‐19 severity
David A. Wells, Diego M. Cantoni, Martin Mayora Neto, Cecilia Di Genova, Alex Sampson, Matteo Ferrari, George Carnell, Angalee Nadesalingam, Peter Smith, Andrew Chan et al. · 2022 · Journal of Medical Virology
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
Jung-Eun Park, Ji-Hee Kim, Jae-Yeon Park, Sung‐Hoon Jun, Hyun‐Jin Shin · 2022 · Virology Journal
B.1.351 SARS-CoV-2 Variant Exhibits Higher Virulence but Less Viral Shedding than That of the Ancestral Strain in Young Nonhuman Primates
Yu Bai, Qian He, Jinghuan Yang, Shuai-Yao Lu, Qun-Ying Mao, Fan Gao, Lian-Lian Bian, Jialu Zhang, Chaoqiang An, Jianyang Liu et al. · 2022 · Microbiology spectrum
Vaccination efficacy in patients with chronic lymphocytic leukemia
Kevin Y. Wang, Pratik Shah, Brandon Skavla, Fatima Fayyaz, Jeffrey Chi, Joanna Meehan Rhodes · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19
Lin Xia, Lunzhi Yuan, Ya-hong Hu, Junyi Liu, Guo-Sheng Hu, Ruoyao Qi, Tian-ying Zhang, Hualong Xiong, Zaozao Zheng, Hong-wei Lin et al. · 2023 · Cellular and Molecular Immunology
Previous BCG vaccination is associated with less severe clinical progression of COVID-19
Susan Martins Pereira, Florisneide Rodrigues Barreto, Ramon Andrade de Souza, Carlos Antônio de Souza Teles Santos, Marcos Emanoel Pereira, Enny S. Paixão, Carla Cristina Oliveira de Jesus Lima, Márcio Natividade, Ana Angélica Bulcão Portela Lindoso, Éder Gatti Fernandes et al. · 2023 · BMC Medicine
T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets
Alexandre Eduardo Nowill, Manuel Caruso, Pedro Otavio de Campos-Lima · 2023 · Frontiers in Immunology
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
Lorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, Julie Røkke Osen, Viktoriia Chaban, Katrine Persgård Lund, Lisa Tietze, Trung The Tran, Fridtjof Lund‐Johansen, Hassen Kared et al. · 2023 · Frontiers in Immunology
Early protective effect of a (“pan”) coronavirus vaccine (PanCoVac) in Roborovski dwarf hamsters after single-low dose intranasal administration
Mohammed O. Abdelaziz, Martin J. Raftery, Julian Weihs, Olivia Bielawski, Richard Edel, Julia K.C. Köppke, Daria Vladimirova, Julia Maria Adler, Theresa C. Firsching, Anne Voß et al. · 2023 · Frontiers in Immunology
SARS-CoV-2–specific antibody and T-cell immunity in convalescents after infection wave in Beijing in late 2022
Xuejiao Guan, Qi Huang, Mei Dong, Maozhong Li, Hui Xie, Xiaofeng Wei, Lu Kang, Xue Wang, Aihua Li, Qing Wang et al. · 2023 · Journal of Infection